4//SEC Filing
ROYSTON IVOR 4
Accession 0001209191-24-004041
CIK 0001061027other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:58 PM ET
Size
8.6 KB
Accession
0001209191-24-004041
Insider Transaction Report
Form 4
ROYSTON IVOR
DirectorCEO & President
Transactions
- Exercise/Conversion
Common Stock
2024-02-25+25,219→ 764,084 total - Exercise/Conversion
Restricted Stock Units
2024-02-25−25,219→ 126,095 total→ Common Stock (25,219 underlying)
Holdings
- 18,599(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Viracta Therapeutics, Inc. Common Stock.
- [F2]One-eighth (1/8th ) of the RSU Award will vest on November 25, 2021 (the "First Vesting Date"), and one-sixteenth (1/16th ) of the RSU Award will vest each Quarterly Vesting Date (as defined below) after the First Vesting Date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Viracta Subsidiary, Inc. 2016 Equity Incentive Plan, the "Plan") through the applicable vesting date. For the purposes of the foregoing, "Quarterly Vesting Date" means February 25, May 25, August 25,and November 25 of each year.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001026765
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:58 PM ET
- Size
- 8.6 KB